Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: current progress and combined approaches (Review)
Oncology Reports · 2026
DOI: 10.3892/or.2026.9082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, 2026. Verfasst von Zhen Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Immunotherapy, Molecular Targeted Therapy, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China.
- Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
- Department of Oncology, Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 610072, P.R. China.
Zitieren
APA
Yang, Z., Liu, H., Chen, M., Zhang, L., Gong, M., & Yu, R. (2026). Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: current progress and combined approaches (Review). Oncology Reports. https://doi.org/10.3892/or.2026.9082
Vancouver
Yang Z, Liu H, Chen M, Zhang L, Gong M, Yu R. Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: current progress and combined approaches (Review). Oncology Reports. 2026. doi:10.3892/or.2026.9082
BibTeX
@article{Yang2026,
author = {Yang, Zhen and Liu, Huajun and Chen, Meilin and Zhang, Liming and Gong, Meiling and Yu, Ruilian},
title = {Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: current progress and combined approaches (Review)},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9082}
}
EUVIMED